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Abstract
Attention Deficit / Hyperactivity Disorder (ADHD) in childhood is associated with impaired 
functioning in multiple cognitive domains: executive functioning (EF), reward and timing. Similar 
impairments have been described for adults with persistent ADHD, but an extensive investigation 
of neuropsychological functioning in a large sample of adult patients is currently lacking. We 
systematically examined neuropsychological performance on tasks measuring EF, delay 
discounting, time estimation and response variability using univariate ANCOVA's comparing 
patients with persistent ADHD (N = 133, 42% male, mean age 36) and healthy adults (N = 132, 
40% male, mean age 36). In addition, we tested which combination of variables provided the 
highest accuracy in predicting ADHD diagnosis. We also estimated for each individual the 
severity of neuropsychological dysfunctioning. Lastly, we investigated potential effects of 
stimulant medication and a history of comorbid major depressive disorder (MDD) on 
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performance. Compared to healthy adults, patients with ADHD showed impaired EF, were more 
impulsive, and more variable in responding. However, effect sizes were small to moderate (range: 
0.05 – 0.70) and 11% of patients did not show neuropsychological dysfunctioning. The best fitting 
model predicting ADHD included measures from distinct cognitive domains (82.1% specificity, 
64.9% sensitivity). Furthermore, patients receiving stimulant medication or with a history of MDD 
were not distinctively impaired. To conclude, while adults with ADHD as a group are impaired on 
several cognitive domains, the results confirm that adult ADHD is neuropsychologically 
heterogeneous. This provides a starting point to investigate individual differences in terms of 
impaired cognitive pathways.
Keywords
Adult ADHD; neuropsychology; heterogeneity; executive function; reward; reaction time 
Variability
INTRODUCTION
Attention Deficit / Hyperactivity Disorder (ADHD) is a common and highly heritable 
neuropsychiatric disorder in childhood that is strongly persistent over time. At least 35% of 
all childhood patients still meet full ADHD criteria in adulthood (American Psychiatric 
Association, 2000), and this percentage is much higher (78%) when partial remitted patients 
are included (Biederman et al., 2010). ADHD has an average prevalence of 2.5–4.9 % in the 
adult population (Simon et al., 2009). The clinical phenotype of ADHD is characterized by 
persistent, age-inappropriate symptoms of inattention, and / or hyperactivity and impulsivity 
(American Psychiatric Association, 2000).
ADHD has been associated with neurocognitive dysfunctioning, and over the years, several 
neuropsychological theories about ADHD etiology have been put forward. One of the most 
influential theories proposed ADHD to arise from a single core deficit in behavioral 
inhibition, which leads to secondary impairments in several executive functions (Barkley, 
1997). However, this assumption of a central deficit was challenged by data showing that 
ADHD patients are impaired in multiple neuropsychological domains. It has therefore been 
proposed that there are distinct pathways to dysfunction, including executive function (EF) 
deficits, delay aversion, and timing problems (Castellanos et al., 2006; Sonuga-Barke et al., 
2010). Although not included in the multiple pathway model, another characteristic of 
ADHD is performance variability. The inconsistency in performance and the high 
prevalence of moment-to-moment variability in reaction times is one of the most 
consistently reported manifestations of ADHD. Reaction time variability (RTV) received 
extensive discussion as an indicator of cognitive performance, although the exact nature of 
high RTV in ADHD is still uncertain (Kofler et al., 2013; Tamm et al., 2012).
Studies of cognitive functioning in adults with ADHD suggest that cognitive impairments 
found in adults resemble those observed in children with ADHD, showing equally moderate 
effects sizes (for meta-analytic reviews, see (Boonstra et al., 2005; Hervey et al., 2004; 
Schoechlin and Engel, 2005). Similar results were derived from qualitative reviews 
(Seidman, 2006; Woods et al., 2002). Recent meta-analyses in adult ADHD focused solely 
Mostert et al. Page 2
Eur Neuropsychopharmacol. Author manuscript; available in PMC 2016 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
on deficits found in working memory (Alderson et al., 2013) and long-term memory 
(Skodzik et al., 2013). Furthermore, recent experimental studies on adult ADHD show 
deficits in attention (Fuermaier et al., 2015; Grane et al., 2014), set-shifiting (Boonstra et al., 
2010; Hallehand et al., 2012; Rohlf et al., 2012) inhibition (Boonstra et al., 2010; Fuermaier 
et al., 2015), (working) memory (Fuermaier et al., 2015; Lundervold et al., 2015; Rohlf et 
al., 2012), delay discounting (Marx et al., 2010), and increased reaction time variability 
(Feige et al., 2013; Gmehlin et al., 2014; Grane et al., 2014).
From the childhood literature, we know that ADHD is characterized by large heterogeneity 
at the neuropsychological level, which means that only a minority of ADHD patients shows 
deficits in each domain and that some patients with ADHD will perform in the normal range 
(Nigg et al., 2005b). Such heterogeneity was illustrated in a recent study on boys with 
ADHD (Coghill et al., 2013). Per cognitive domain merely 18–36% of the patients had an 
impairment, while 25% of the sample did not show deficient performance in any of the 
cognitive domains.
Heterogeneity in cognitive performance within a sample of ADHD patients may also arise 
from differences in medication use or comorbidity. Stimulants are effective for the treatment 
of clinical symptoms in adult ADHD (Faraone et al., 2004) and also in neuropsychological 
studies medication is usually seen as a potential moderator. Many neuropsychological 
studies in ADHD have included patients who had previously taken, or were receiving 
stimulant medication at the time of the study. To eliminate the acute effects of medication, 
most studies used a washout period (24h or 48h). However, stimulants may act longer than 
48h (McCarthy et al., 2014). Similarly, ADHD patients with a comorbid psychiatric disorder 
showed greater neuropsychological deficits than ADHD patients without comorbidity 
(Hervey et al., 2004) and may represent a distinct subgroup, with different cognitive profiles 
(Fischer et al., 2007). However, it has also been shown that cognitive deficits in adult 
ADHD cannot be accounted for by comorbid disorders (Nigg et al., 2005a; Silva et al., 
2013). Major depressive disorder (MDD) is the most frequently observed comorbidity, and 
can co-occur with ADHD in up to 50% of the cases (Wilens et al., 2009). MDD has been 
associated with cognitive difficulties in memory, attention and problem-solving. Only two 
studies examined comorbid MDD in ADHD to date, both suggesting that current comorbid 
MDD symptoms may not influence neuropsychological profiles in ADHD (Katz et al., 1998; 
Riordan et al., 1999). While potential effects of comorbid MDD on cognition are often 
controlled for by excluding patients with current MDD from a study, many included patients 
will have remitted MDD. It is currently not known whether adult ADHD patients with MDD 
in remission are distinctively impaired on cognitive performance, although it has been 
shown that ADHD symptom severity increases in association with lifetime occurrence of 
comorbid MDD (Simon et al., 2013).
Reviewing the literature of adult ADHD shows that experimental studies and meta-analyses 
are limited by relying on relatively small samples with different inclusion criteria and tasks. 
Those studies had limited power to investigate confounding effects on neuropsychological 
functioning such as comorbidity or treatment. Also, the investigation of different tasks or 
functions in different samples has limited the possibility to construct a comprehensive 
picture of impairments associated with adult ADHD. To improve confidence in the findings, 
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replication/validation in a large cohort of adult ADHD patients is thus desirable. Lastly, 
except for studies by Seidman et al. (1998), Boonstra et al. (2010), and Fuerrmaier et al. 
(2015), most studies assessed only a narrow range of neuropsychological tasks. Therefore, 
we investigated case-control differences on a wide range of well-described 
neuropsychological tasks using the largest sample of adult ADHD patients to date. 
Neuropsychological tasks were chosen based on the multiple pathway model and RTV 
literature described above and measured motor speed, sustained attention, inhibition, delay 
discounting, time estimation, set-shifting, verbal fluency, working memory, and response 
variability. We expected effect sizes to be moderate, with strongest effects on RTV as this is 
a pervasive characteristic observable across tasks (Kofler et al., 2013). Furthermore, we 
were interested in the diagnostic relevance of these tasks. From a clinical perspective it is 
interesting to know the predictive importance of neuropsychological measurements in 
ADHD classification. Previous literature showed however that neuropsychological 
measurements have a relatively poor ability to discriminate between children with ADHD 
and typically developing controls (Sjowall et al., 2013) or adults with ADHD and 
psychiatric patients without ADHD (Holst and Thorell, 2013). It remains an open question 
how discriminative the investigated neuropsychological tasks are in a sample of healthy 
adults with and without ADHD. We further investigated heterogeneity in performance and 
severity by computing the number of deficient test scores per participant as was previously 
done in childhood ADHD (Coghill et al., 2013). Additionally, we explored the potential 
effect of stimulant medication and a history of comorbid MDD on performance.
EXPERIMENTAL PROCEDURES
Participants
The study population was the Dutch cohort of the International Multicenter persistent 
ADHD CollaboraTion (IMpACT - http://impactadhdgenomics.com (Franke et al., 2010)). 
This is an ongoing study that at the time of analysis (1 January 2014) included 298 
participants (155 adult ADHD cases, 143 healthy comparison participants). Patients and 
healthy control participants were recruited at the department of Psychiatry of the Radboud 
university medical center in Nijmegen and through advertisements. Patients were included if 
they had previously been diagnosed with persistent ADHD, i.e. present since childhood, by a 
psychiatrist according to the Diagnostic and Statistical Manual of Mental Disorders (4th 
edition; DSM-IV-TR; American Psychiatric Association, 2000). Exclusion criteria for 
participants were psychosis, alcohol or substance addiction in the last six months, current 
major depression, full-scale IQ estimate <70, neurological disorders, sensorimotor 
disabilities, non-Caucasian ethnicity, medication use other than psychostimulants, 
atomoxetine or bupropion and failure to withhold stimulant medication 24 hours prior to 
testing (see procedure below). Additional exclusion criteria for healthy controls were a 
current or lifetime neurological or psychiatric disorder in either the proband or his/her first-
degree relatives. From the total sample, 33 participants (22 patients, 11 controls) had to be 
excluded because they met at least one of these exclusion criteria (see Supplementary Table 
1).
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This study was approved by the regional ethics committee (Centrale Commissie 
Mensgebonden Onderzoek: CMO Regio Arnhem – Nijmegen; Protocol number III.
04.0403). Written informed consent was obtained from all participants.
Procedure
Subjects were invited for two sessions (Supplementary Figure 1), one including a detailed 
psychiatric assessment and blood withdrawal for biobanking of DNA, RNA and serum. A 
second session consisted of cognitive testing and neuroimaging procedures. The genetic and 
neuroimaging data are described elsewhere (i.e. (Franke et al., 2010; Hoogman et al., 
2011)). For session 2, participants were requested to withhold stimulant medication 24 hours 
prior to testing.
Psychiatric assessment
Both patients and controls were assessed using the structured Diagnostic Interview for 
ADHD in Adults (DIVA, (Kooij, 2010)). This interview focuses on the 18 DSM-IV 
symptoms of ADHD and uses concrete and realistic examples to thoroughly investigate 
whether a symptom is currently present or was present in childhood. In addition, a self-
report questionnaire on current symptoms was obtained using the ADHD Rating Scale-IV 
(Kooij et al., 2005). The Dutch version of the Structured Clinical Interview for DSM-IV, 
SCID-I and SCID-II (Groenestijn et al., 1999; Weertman et al., 2000) was used to identify 
lifetime Axis I and II disorders. Twenty-two patients and 12 controls did not participate in 
the clinical interview. These participants were included in the main analysis based on a prior 
diagnosis of ADHD by a psychiatrist and if they reached clinical threshold for ADHD based 
on the self-report scale. They were excluded from the analysis of comorbidity (see below).
Neuropsychological measurements
The neuropsychological test battery included measures tapping into EF (working memory, 
attention, inhibition, set-shifting, verbal fluency), delay discounting, and time estimation. 
Details about tasks and main outcome measures are described in Table 1 and the 
supplementary text. To estimate IQ, Vocabulary and Block Design of the Wechsler Adult 
Intelligence Scale (WAIS-III) were administered (Wechsler, 1997). The tests were always 
administered in the same order.
Data analysis of neuropsychological tasks
All measures were entered as raw scores in the analyses. Performance on each 
neuropsychological measure was entered as the dependent variable in separate univariate 
ANCOVA's, testing the difference between patients and controls. Age and gender were 
entered as covariates of no interest in order to reduce error variance (Miller & Chapman 
2001). This was justified as age and gender did not differ between the groups. We therefore 
also did not investigate interactions between diagnosis and age or gender. As IQ is 
correlated with performance on many neuropsychological tasks, we investigated whether 
adding estimated IQ as an additional covariate would influence the findings. As IQ also did 
not differ between groups, this analysis using ANCOVA was justified and did not serve to 
control for IQ. Assumptions with respect to the residuals were checked and 
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neuropsychological measures were transformed if necessary. Outliers were defined as 
having a score more extreme than four times the standard deviation above or below the 
mean per group (Leth-Steensen et al., 2000; Nigg et al., 2005a). This threshold guarded 
against artifacts and chance level performance, while still including cases performing at the 
extreme of the normal distribution. If a participant's score was an outlier on one outcome 
variable of a task, his/her scores on all outcome variables from that task were excluded. 
Effect sizes were computed as Cohen's D, using the corrected means from the ANCOVA's 
(Cohen, 1988).
Multiple comparison correction was performed by estimating the effective number of 
independent tests (Meff) (Li and Ji, 2005). This method takes into account the correlation 
structure between measures and calculates the Meff based on the observed eigenvalue 
variance of the different neuropsychological measures using the matSpD interface (http://
genepi.qimr.edu.au/general/daleN/matSpD). The p-value for significance was determined as 
0.05 divided by Meff. Twenty-seven measures resulted in twenty-two independent tests and 
therefore, only effects with a p-value < 0.0023 were considered significant.
Second, to investigate discriminating ability of the neuropsychological test battery, we used 
a step-wise backward logistic regression model. To maximize power, with our sample size, 
we included only those neuropsychological measures that were nominally significant in the 
case-control comparison to determine the model with the highest prediction accuracy of 
diagnostic status. Variables were retained in the model when they significantly contributed 
to the likelihood ratio statistic, all other variables were excluded.
To investigate heterogeneity in cognitive impairments, we computed the number of deficient 
test scores for each participant. Similar to previous studies, a deficient score was defined as 
performance below the 10th percentile of the performance distribution of the control group 
(Coghill et al., 2013; Nigg et al., 2005b). For variables where higher scores indicated worse 
performance, deficiency was defined as a score above the 90th percentile of performance 
distribution of the control group. For the variable `time estimation median response time' 
performance at both lower and upper extreme was scored as deficient. As not all participants 
had completed data for all tasks, we computed the relative number of deficient test scores as 
a percentage of the total number of scores for that participant. We labeled between 1% and 
20% deficient test scores as `mildly impaired', between 20% and 40% as `impaired' and 
above 40% as `severely impaired'. The difference between cases and controls in the number 
of relative deficient test scores was computed using an ANCOVA with age and gender as 
covariates. In addition, we repeated the same analysis in a restricted group of only those 
participants with complete data (N = 168).
Effects of stimulant medication and history of MDD
We conducted two exploratory analyses. First, in order to investigate stimulant medication 
effects on neuropsychological measures, we used separate ANCOVA's for each 
neuropsychological measure comparing medication naïve patients (N = 20), medicated 
patients (N = 83), and healthy control participants (N = 132), with age and gender as 
covariates. Second, we conducted a similar analysis comparing patients with at least one 
lifetime MDD episode (now in remission, N = 55), patients without a history of MDD (N = 
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68), and healthy controls without prior episodes of MDD (N = 112). Twenty healthy control 
participants reported to have experienced depressive episodes in the past and were therefore 
excluded from this analysis. For both analyses, in the case of a main effect of group on the 
neuropsychological measure, we tested post-hoc the differences between groups. These 
post-hoc tests were Bonferroni corrected for multiple testing.
RESULTS
Demographics
A total of 265 participants (132 healthy controls and 133 ADHD patients) were included in 
the analyses. Demographic information is provided in Table 2. Patients and controls did not 
differ in age, handedness, and estimated IQ. Gender was equally distributed across groups. 
Patients had received fewer years of education than controls. As expected, patients had 
significantly more ADHD symptoms based on the diagnostic interview and self-report. 
Information about psychiatric comorbidities and medication is summarized in 
Supplementary Tables 2 and 3.
Effect of diagnosis on cognitive performance
Findings from the case-control comparison of neuropsychological performance are 
summarized in Table 3. In the domain of EF patients were impaired on working memory 
and attention, but no group differences were found for inhibition (Flanker and SART task) 
and verbal fluency. In the domain of delay aversion patients performed worse than controls 
on the delay discounting task, but not in the domain of timing (time estimation task). Across 
several tasks, patients were also more variable in their reaction times than controls. 
Response speed did not differ between patients and controls in most tasks, except for both 
conditions of the Trailmaking tasks. Effect sizes were in the small to medium range, with the 
largest effect on the SA-dots task where patients showed more fluctuation in errors across 
blocks (effect size = −0.71). Adding the covariate IQ, in addition to age and gender, did not 
significantly alter the results.
Variables predicting ADHD diagnosis
A stepwise backwards logistic regression identified six out of 17 variables to significantly 
contribute to a model predicting diagnosis: Digit span (forward), Flanker (total SD of RT), 
SAdots (SD series errors and response bias), Delay discounting (k100) and Time estimation 
(absolute median deviation from 1000ms). The entire model significantly distinguished 
patients from controls (Log-likelihood = 174.13, R2 (Nagelkerke) = 0.39, χ2 = 57.54 (6 df), 
p < 0.001) and had a sensitivity (correctly predicting patients) of 64.9% and a specificity 
(correctly predicting controls) of 82.1%. Model details are shown in Supplementary table 4.
Number of deficient test scores across all outcome measures
Patients had deficient test scores on a significant larger proportion of variables than controls 
(mean controls = 9.16% (SD = 9.23), mean ADHD = 15.82% (SD = 13.55), F = 22.34 
(1,261), p < 0.001). This effect remained when only including participants with complete 
data (F = 13.08 (1,164), p < 0.001). As apparent from Figure 2, there was a large variability 
between individual patients, with some patients not having any deficient scores (11%), while 
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others were severely impaired (5%). The majority (62%) of patients was mildly impaired, 
and 23% was impaired. This variability was also present in the control group, although here 
the majority of participants (64%) had deficient scores on 10% or less of the outcome 
variables.
Effects of stimulant medication and history of MDD on neuropsychological measures
We additionally investigated the effect of stimulant medication on neuropsychological 
performance by comparing medication naïve patients, medicated patients and controls. 
Group effects where all in the same direction as in the main case-control analysis, although 
smaller (Supplementary Table 5). Post-hoc comparisons indicated that on the time 
estimation task medication naïve patients responded faster than medicated patients and 
controls.
The main effects from the case-control analyses were also reproduced when comparing 
healthy controls to ADHD patients with and without a history of MDD (Supplementary 
Table 6). On none of the neuropsychological measures did patients with a history of MDD 
differ from patients without this comorbidity. However, on several measures patients with a 
history of MDD did not differ from controls and patients without MDD, despite a main 
effect of group.
DISCUSSION
In this study we examined the neuropsychological performance of a large group of patients 
with persistent ADHD and healthy adult control participants on a broad range of 
neuropsychological tasks. As a group, patients with ADHD showed impaired EF, especially 
working memory and sustained attention, were more sensitive to delay aversion, and had 
increased response variability as compared to healthy controls. Stepwise logistic regression 
analysis showed that measures from distinct cognitive domains collectively contributed to 
the predictive model explaining variance in ADHD. Despite this, the model had limited 
predictive power for diagnostic status. Cognitive heterogeneity of the sample was also 
apparent from large inter-individual variability in the number of deficient test scores, 
especially in the ADHD group, but also in controls. Strikingly, no case-control differences 
were found in tasks measuring inhibition and timing in our test battery. Effect sizes were 
small to moderate, and medication and a history of MDD comorbidity did not explain 
differences in performance in adult ADHD.
As described, a popular model of childhood ADHD implicates three neuropsychological 
pathways in childhood ADHD, one involving EF deficits, one involving altered reward 
processing, and one involving temporal processing deficits (Castellanos et al., 2006; 
Sonuga-Barke et al., 2010). We report evidence for impairment in EF and reward 
processing, but not in temporal processing in patients with persistent ADHD. Our finding 
that EF deficits are primarily related to working memory and sustained attention is in 
agreement with the adult ADHD literature (Boonstra et al., 2005; Hervey et al., 2004). This 
result stresses the significance of attentional problems in adult ADHD and may reflect the 
fact that the symptoms of hyperactivity and impulsivity decrease as ADHD children 
approach adulthood (Biederman et al., 2000). It has been suggested that IQ may play a role 
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in explaining working memory and attention deficits in adult ADHD (Boonstra et al., 2010; 
Murphy et al., 2001). However, as the groups did not differ on IQ, and covarying for IQ did 
not alter the results, this explanation is unlikely.
Contrary to expectations, we did not find EF differences related to inhibition, set-shifting, or 
verbal fluency. The ability to inhibit a response has been posited as a core domain impaired 
in ADHD (Barkley, 1997), and has been found in several studies of adult ADHD (Boonstra 
et al., 2010; Boonstra et al., 2005; Hervey et al., 2004), though not in others (Gmehlin et al., 
2014; Halleland et al., 2012). We used the SART and Flanker tasks to measure inhibition, 
but are cautious to interpret our null findings as strong evidence against inhibition deficits in 
adult ADHD. First, the Flanker task showed a ceiling effect in inhibition errors, which is 
consistent with findings in early adolescence (Drechsler et al., 2005; Harms et al., 2014). 
This task may therefore lack sensitivity to measure inhibition impairments in adult ADHD. 
Second, on the SART, the number of commission errors (measuring inhibition) did not 
differ between patients and controls, nor did the number of omission errors (measuring 
attention). To better characterize inhibition deficits in adult ADHD, a more sensitive 
measure would be the stop signal reaction time as measured with a stop signal task. Such a 
task is unique in that is has variable inter-stimulus intervals often at a rapid pace that 
requires participants to interrupt an already ongoing response. This task design may provoke 
impulsive responses among participants more strongly and may thus be more sensitive to 
inhibition problems in ADHD (Epstein et al., 2001). Indeed, manipulation of response 
prepotency was effective in evoking response inhibition difficulties in adult ADHD patients 
(Grane et al., 2014).
Set-shifting is another component of EF, which we measured using part B of the 
Trailmaking task. Even though patients were slower on this part of the task, they were 
equally slow on part A, which measures motor speed (Nigg et al., 2005a). This finding is in 
line with other studies in adult ADHD suggesting that deficits in set-shifting are explained 
by impaired processing speed (Rohlf et al., 2012). We thus conclude that set-shifting as 
measured with the Trailmaking task was not impaired in the adult ADHD group. Lastly, 
patients did not differ from controls in verbal fluency measures, which contradicts previous 
findings (Boonstra et al., 2005; Hervey et al., 2004). This could be due to the good IQ-
matching between patients and controls in our sample, whereas in other studies patients had 
lower IQ than controls. In children it was found that IQ significantly correlated with verbal 
fluency (Ardila et al., 2000). Hence, previously reported differences in verbal fluency may 
be more attributable to differences in IQ than to ADHD.
Delay aversion may represent a second neuropsychological pathway towards ADHD, linked 
to altered processing of rewards (Sonuga-Barke, 2002). Our results of stronger delay 
discounting in patients are in line with other evidence of increased impulsive decision 
making in persistent ADHD (Paloyelis et al., 2009)(Marx et al., 2010). The tendency to 
prefer immediate (smaller) over delayed (larger) rewards is also considered to be an aspect 
of impulsivity potentially important for the development of substance use disorders (Dick et 
al., 2010). Therefore, stronger delay aversion might represent a vulnerability marker for 
substance abuse in ADHD (Bickel et al., 2012). A third pathway involves temporal 
processing deficits (Sonuga-Barke et al., 2010). In the present study, patients did not differ 
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from controls on timing accuracy using a time estimation task with an interval of one 
second. These findings are supported by a recent study using the same task, which showed 
deficits in time estimation accuracy were present in adolescents with ADHD, but not in 
adults (Thissen et al., 2014). However, another study, which examined time estimation in 
adults with ADHD using several time intervals (2, 6, 12, 24, 36 and 48 seconds), found that 
the patients produced errors predominantly at interval durations of 36 and 48 seconds (Marx 
et al., 2010). This may suggest that tasks using an interval of one second may not be 
sensitive enough to measure existing timing deficits in adult ADHD.
In the analyses comparing patients and controls the largest effect sizes were observed for 
measures of performance variability, both in terms of fluctuations in errors as in reaction 
times. This confirms our hypothesis, which was based on previous studies identifying RTV 
as one of the most robust features of ADHD (Kofler et al., 2013; Tamm et al., 2012). 
Notably, the average reaction time on the tasks used to measure RTV did not differ between 
patients and controls, supporting the notion that RTV is not attributable to differences in 
processing speed (Kofler et al., 2013). Rather, RTV is thought to reflect lapses in attention 
that produce a skewed reaction time distribution with a large tail (Leth-Steensen et al., 
2000). More thorough investigation of RTV used ex-Gaussian modeling and showed that 
increased RTV is partly due to overly slow responses (Feige et al. 2013; Gmehlin et al., 
2013; Wolfers et al., 2015). These slow responses are reflected by the ex-Gaussian 
parameter tau, which represents the exponential component of the reaction time distribution. 
Recently, we showed that the tau parameter was associated with the microstructural integrity 
of the right superior longitudinal fasciculus, a white matter tract implicated in both attention 
and ADHD (Wolfers et al., 2015). Taken together, such findings suggest a neurobiological 
basis for within-subject variability in ADHD. Interestingly, we observed the largest effect 
size for the variance in errors made during the SA-dots task. This is a promising novel 
measure for future studies on sustained attention in ADHD using a continuous performance 
task.
We achieved limited accuracy in predicting ADHD diagnosis from neuropsychological 
performance, despite the large number of cognitive test variables available. This is 
consistent with what was previously found in children with ADHD (Sjowall et al., 2013). 
The best fitting predictive model included six measures from different cognitive domains 
(EF, response variability, timing and delay aversion) and reached 82.1% specificity and 
64.9% sensitivity. This rather low sensitivity makes a test based on cognitive measures 
insufficient as a diagnostic tool for ADHD in clinical practice. The variables retained in the 
final model of the logistic regression could be influenced by outliers, as these can be 
expected to contribute strongly to the model. However, all extreme outliers were removed 
from the data before data analysis, reducing the effect of erroneous data on the model. 
Rather, the variables in the model are likely to be most sensitive to behavioral impairments 
associated with ADHD, as was also reflected in the effect sizes of most of these variables in 
the case-control analysis. Importantly, measures from distinct cognitive domains collectively 
contributed to the model, indicating that there is not a single cognitive task or domain 
sufficient for explaining ADHD on the group level. This is in agreement with the theory of 
multiple pathways leading to impairment in ADHD (Sonuga-Barke et al., 2010). Besides 
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that heterogeneity can be explained by impairments in multiple cognitive pathways, we also 
observed differences in severity of impairments between individuals. The majority of 
patients were impaired on less than 20% of all cognitive measures, and while a small 
proportion of patients had more than 40% deficient test scores, 11% of patients did not show 
any deficit. This is in line with studies in childhood ADHD (Coghill et al., 2013; Nigg et al., 
2005b; Sonuga-Barke et al., 2010). Importantly, only 23% of our healthy control 
participants did not show any deficits, which is much lower than the previously reported 
53% and 60% (Coghill et al., 2013; Nigg et al., 2005b). However, these differences between 
studies can be explained by the fact that the current study included many more variables (27 
instead of four and six). Furthermore, the majority of controls fell in the `mildly impaired' 
group, which means they performed deficiently on 1–20% of the tasks. Seeing that the 
criterion for having a deficient test score was performing at the extreme of the control 
distribution, it would be expected that controls perform deficiently on some tasks.
The current findings provide a starting point to investigate individual differences in terms of 
impaired cognitive pathways, for instance by using clustering analyses on the 
neuropsychological data (Fair et al., 2012). Such an approach follows the recently proposed 
strategy by the NIMH, called Research Domain Criteria (RDoC) to investigate mental 
disorders in a dimensional instead of categorical manner (http://www.nimh.nih.gov/
research-priorities/rdoc/index.shtml). Neurocognitive measures can be used to characterize 
psychopathology without being restricted to current disorder categories. This will aid in the 
understanding of the neurobiological and behavioral underpinnings of mental disorders. 
Furthermore, neuropsychological investigations may be helpful for clinicians in 
characterizing individual differences, allowing more personalized treatments.
We did not find evidence for subgroups within the patient group, neither due to stimulant 
medication treatment nor history of comorbid MDD, which could explain the observed 
cognitive heterogeneity. Medication use did not influence task performance in our 
exploratory analysis; medication naïve patients performed similar to medicated patients. 
Mechanisms linking pharmacological actions of stimulants to neuropsychological processes 
are speculative, although our results support observations that, in adult ADHD, stimulants 
seem to produce little improvement on a variety of neuropsychological tasks (Advokat, 
2010; Turner et al., 2005). Similarly, the group of patients with a comorbidity in the form of 
a history of MDD did not seem to differ greatly from the group without this comorbidity in 
terms of neuropsychological functioning. This extends earlier findings and suggest that 
ADHD patients diagnosed with current or remitted MDD show similar neuropsychological 
profiles as patients diagnosed with ADHD alone (Katz et al., 1998; Riordan et al., 1999). It 
should be noted however that this study was not set up to investigate the effects of stimulant 
medication or differences between patients with and without a history of comorbid MDD, 
hence these effects should be investigate further.
The findings presented here should be considered in light of several strengths and 
weaknesses. This study is unique in its large, well-defined naturalistic sample of patients and 
a well-matched control sample. We have used a large battery of tasks covering EF, timing, 
and delay aversion domains. This allows our findings to be interpreted on the scale of 
cognitive domains instead of on a task-specific level. Our sample was large enough to 
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investigate effects of (at least one) comorbidity. However, our investigation of the effect of 
stimulant medication was likely underpowered as there were only 20 medication naïve 
patients in our sample. Investigating the effects of stimulant medication in adults is 
challenging, as by definition these patients have been symptomatic for a long period. It 
would therefore be more relevant to investigate the effect of medication duration across 
patients, but this requires well-documented medication use history, which was not available. 
Additionally, our findings are limited by the tasks included in our testing battery. We did not 
include measures tapping into the domains of planning or decision making, which are also 
important in ADHD psychopathology. Furthermore, our measures of time estimation could 
be improved by having longer timing intervals. Similarly, inhibition could be measured by 
computing stop-signal reaction times from a stop signal task. Including such measures might 
improve the predictive power for diagnostic status.
To conclude, our study provides novel insights into adult ADHD neuropsychology as well 
as confirmation of findings observed in earlier, smaller studies. In summary, our study adds 
to the literature in the following ways: 1) compared with previous studies, our sample size is 
almost two (Seidman et al. 1998) or three times larger (Boonstra et al. 2010; Fuermaier et al. 
(2015); 2) we also examined delay aversion and timing deficits which was not sufficiently 
covered by previous work; 3) while other studies investigated variability in reaction times 
only, we also investigated variability in errors made during a continuous performance task; 
4) we investigated confounding effects of depression history and stimulant treatment (the 
ADHD patient samples from Seidman et al. (1998) and Boonstra et al. (2010) were all 
medication-naïve); 5) ours was the first study in adult ADHD to calculate the number of 
deficient test scores per participant as was previously done in childhood ADHD (Coghill, 
2013); 6) we studied not only simple group differences but also measures of sensitivity and 
specificity to examine the discriminatory ability of the neuropsychological test battery in 
adult ADHD. Our comprehensive analysis of cognitive performance in a large sample of 
patients with persistent ADHD and well-matched healthy control participants confirms that 
several cognitive domains are affected in the adult ADHD population, with moderate effect 
sizes. Both the ADHD and the control sample were heterogeneous in their cognitive 
performance, with large differences in the number of tasks on which participants scored 
deficient. In line with this, a predictive model including measures from several domains had 
limited power to predict diagnostic status. Neuropsychological tasks may therefore be more 
relevant for characterizing individual impairments that can specifically be targeted with 
personalized treatment. Future studies focusing on inter-individual differences in 
performance of patients may aid in a better understanding of ADHD etiology and its 
persistence, also in terms of the underlying biology.
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Figure 1. Differences in performance between ADHD patients and controls on measurements 
from several cognitive domains
Bar graphs indicate the average performance per group for each neuropsychological measure 
(time estimation absolute median deviation from 1000ms is not shown); error bars represent 
the standard error of the mean. Dark grey bars represent the healthy control group, lighter 
grey bars represent ADHD patient group. An asterix (*) indicates measures where patients 
differed significantly from controls.
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Figure 2. Deficient test scores across participants
For each participant, deficient test scores were computed as the number of test scores that 
were below the score of the bottom 10% of the control group, divided by the total number of 
test scores of that participant and multiplied with 100%. The sections indicate the percentage 
of participants that had a deficient test score within a certain bin. `Mildly impaired' are 
participants with 1–20% deficient test scores, `impaired' are those with 20–40% deficient 
test scores and those with more than 40% deficient were labeled as `severely impaired'.
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Table 1
Tasks and outcome measures of the neuropsychological test battery
Task Task description* Cognitive domain Outcome measure
1. Baseline speed task Participants respond with a button press as 
quickly as possible when a fixation cross 
changes into a block-shape
Motor speed & reaction time Mean RT
SD of RT
2. WAIS-III Digit 
span task
Participants repeat strings of digits that are 
read aloud by the experimenter. In the 
backward condition, strings are repeated in 
reverse order. Each trial the working 
memory load increases.
Executive functioning: Working 
memory
Forward digit span score
Backward digit span score
3. Flanker task Participants respond with a button press to 
the color of the center block (yellow or 
blue), flanked by other blocks. In part 1, 
the center block is flanked by blocks of the 
same color (congruent trial) or a different 
color (green, neutral trial). In part 2, the 
neutral trials are replaced by incongruent 
trials (flanking blocks with the color of the 
alternative response).
Executive functioning: Inhibition Total mean RT (average over 
part 1 and 2)
Total SD of RT (average over 
part 1 and 2)
Inhibition RT (difference in 
RT on congruent and 
incongruent trials in part 2)
Inhibition errors (difference in 
error rate between congruent 
and incongruent trials in part 
2)
4. Sustained attention 
dots task (SA-dots)
Three, four or five dots are presented on 
the screen. Participants respond with a 
button press with the dominant hand to four 
dots and with the non-dominant hand to 
three or five dots. An erroneous button 
press to three or five dots is a false alarm; 
an erroneous button press to four dots is a 
miss. For analysis, the task is split up into 
ten blocks, or series, in order to compute 
variance in performance over time. The 
duration of task is 20 minutes.
Executive functioning: Attention & 
inhibition
Mean series completion time
SD series completion time
SD series errors (SD of the 
errors made across blocks)
Response bias (the difference 
between the number of misses 
and the number of false alarms 
across the entire task)
5. Sustained 
Attention to 
Response Task 
(SART)
Go/No-Go task. Participants respond with a 
button press to single digits presented on 
the screen (1–9), but to withhold a response 
when the digit 3 is presented.
Executive functioning: Attention & 
inhibition
Number of commission errors
Number of omission errors
Mean RT hits
SD of RT hits
6. Trailmaking task Participants need to connect dots 
containing numbers in consecutive order 
(part A) or alternating between numbers 
and letters in consecutive order (part B).
Executive functioning: Motor 
control & set-shifting
Time to complete part A
Time to complete part B
Difference in time to complete 
part B and time to complete 
part A
7. Semantic category 
and initial letter 
fluency
Participants name as many animals or 
professions they can think of in one minute. 
Next, they name as many words starting 
with a `D', `A' or `T' as they can think of in 
one minute.
Executive functioning: Verbal 
fluency
Number of words mentioned in 
category animals
Number of words mentioned in 
category professions
Number of words mentioned in 
category letters (total of 3 
letter-trials)
8. Delay discounting 
task
Participants repeatedly have to choose 
between two hypothetical incentives that 
differ in the value (money) and delay (time 
until the money would be received). The 
impulsivity parameter (k) is computed from 
the present value of the delayed reward 
(V), the real value of the delayed reward 
(a) and the delay in days (D) with the 
formula: V = a/(1+kD).
Delay aversion & impulsivity K 100 (impulsivity high 
rewards)
K 30 (impulsivity intermediate 
rewards)
K 10 (impulsivity low 
rewards)
9. Time estimation 
task
Participants have to respond with a button 
press exactly one second after hearing a 
sound beep. First, during a training session 
the length of a second is shown several 
times. During the experiment, feedback is 
given (`too slow', `correct', `too fast').
Timing Median response time
Absolute deviation of the 
median response time from 
1000 ms
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RT = reaction time; SD = standard deviation; ms = milliseconds.
*
More detailed information about the tasks, including references, can be found in the Supplementary Materials.
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Table 2
Demographics (N = 265a)
Healthy controls (N = 132) ADHD patients (N = 133) p-value
Gender 53 (40.2%) male 56 (42.1%) male n.s.
Age 36.30 (11.75), range 19–63 35.56 (10.40), range 18 – 59 n.s.
Estimated IQb 109.97 (14.90) 107.83 (14.28) n.s.
Educationc 5.16 (0.81), range 3 – 7 4.70 (0.80), range 2 – 7 < 0.001
Repeated school years (once or more) 53 (40.2%) 77 (57.9%) 0.005
Non-completed education programs (one 
or more)
40 (33.3%) (N = 128) 87 (67.4%) (N = 129) < 0.001
Handedness 115 (87.1%) right, 13 (9.8%) left, 3 (2.3%) 
ambidextrous (N = 131)
113 (85%) right, 16 (12%) left, 4 (3%) 
ambidextrous
n.s.
Inattentive symptoms (DIVA) 0.39 (0. 83), 0 – 4 (N = 120) 7.38 (1.55), 3 – 9 (N = 112) < 0.001
Hyperactive / impulsive symptoms 
(DIVA)
0.52 (0.98), 0 – 4 (N = 120) 5.76 (2.27), 0 – 9 (N = 112) < 0.001
Total symptoms (DIVA) 0.91 (1.43), 0 – 8 (N = 120) 13.14 (2.76), 7 – 18 (N = 112) < 0.001
Inattentive symptoms (selfreport) 0.53 (0.98), 0 – 5 (N = 131) 6.40 (2.09), 0 – 9 < 0.001
Hyperactive / impulsive symptoms 
(selfreport)
0.89 (1.44), 0 – 6 (N = 131) 5.58 (2.26), 0 – 9 < 0.001
Total symptoms (selfreport) 1.42 (2.14) 0 – 9 (N = 131) 11.98 (3.37), 1 – 18 < 0.001
Data show as: mean (standard deviation), minimum – maximum. P-values represent the significance of the group difference, tested with 
independent samples t-tests for continuous data or Pearson Chi-square tests for categorical data;
a32 subjects from the total sample were excluded from analyses according to our exclusion criteria;
b
IQ was estimated based on performance on the WAIS-III block pattern and vocabulary tasks;
c
Education level was coded from 1 (unfinished primary school) to 7 (post-university);
d
DIVA interview data was missing for 22 patients.
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Table 3
Case/control analysis of cognitive performance (N = 265)
NPO Task Variable Healthy Controls
Mean (SD)
ADHD
Mean (SD)
ANCOVA
F (df), p-value
Effect size
Cohen's D
1. Digit span test
HC: N =132
ADHD: N = 128
Forward score 9.83 (2.36) 8.99 (1.95) 10.45 (1, 256), p = 0.001* 0.40
Backward score 7.49 (2.34) 6.69 (2.22) 8.62 (1,256), p = 0.004 0.37
2. Baseline speed (ANT)
HC: N =130
ADHD: N = 129
Mean RT 313.28 (49.42) 316.83 (55.29) 0.40 (1, 255), n.s. −0.07
SD of RT † 4.08 (0.53) 4.26 (0.57) 7.47 (1,255), p = 0.007 −0.34
3. Flanker task (ANT)
HC: N =127
ADHD: N = 123
Total mean RT 525.37 (73.00) 537.93 (92.87) 1.85 (1, 246), n.s. −0.18
Total SD of RT 93.74 (37.04) 118.39 (58.87) 15.90 (1, 246), p < 0.001* −0.51
Inhibition RT 28.44 (28.25) 23.13 (40.76) 1.45 (1, 246), n.s. 0.14
Inhibition errors 0.68 (1.48) 0.63 (1.47) 0.11 (1, 246), n.s. 0.05
4. SAdots (ANT)
HC: N =128
ADHD: N = 123
Mean series completion time 899.05 (129.21) 944.71 (186.08) 5.03 (1,247), P = 0.026 −0.28
SD completion time † 3.81 (0.44) 4.07 (0.53) 16.82 (1, 247), p < 0.001* −0.52
SD errors † 0.70 (0.19) 0.86 (0.26) 32.03 (1,247), p < 0.001* −0.71
Response bias 5.05 (6.10) 9.16 (9.51) 18.35 (1,247), p < 0.001* −0.52
5. SART
HC: N = 110
ADHD: N = 104
Commission errors 9.31 (5.03) 10.51 (4.87) 3.02 (1,210), n.s. −0.25
Omission errors 2.63 (3.57) 4.04 (4.97) 5.72 (1,210), p = 0.018 −0.32
Mean RT hits 315.50 (57.48) 326.09 (60.74) 2.44 (1,210), n.s. −0.21
SD or RT † 4.35 (0.36) 4.56 (0.44) 14.17 (1,210), p < 0.001* −0.53
6. Fluency
HC: N = 132
ADHD: N = 131
Category; Animals 27.76 (5.77) 25.85 (5.97) 6.84 (1,259), p = 0.009 0.32
Category: professions 20.27 (5.23) 19.81 (5.09) 0.48 (1,259), n.s. 0.10
Letters 41.91 (10.51) 38.95 (10.87) 5.15 (1,259), p = 0.024 0.29
7. Time estimation
HC: N = 126
ADHD: N = 116
Median response time 1007.09 (67.61) 997.94 (82.21) 1.13 (1,238), n.s. 0.14
Absolute deviation of the 
median response time from 
1000 ms
49.38 (46.38) 63.92 (51.40) 5.49 (1,238), p = 0.020 −0.30
8. Delay Discounting
HC: N = 123
ADHD: N = 109
K 100 † −5.25 (1.54) −4.50 (1.65) 12.85 (1,228), p < 0.001* −0.48
K 30 † −4.76 (1.65) −4.38 (1.66) 3.15(1,228), n.s. −0.23
K 30 † −4.39 (1.43) −3.97 (1.67) 4.43(1,228), p = 0.036 −0.27
9. Trailmaking task
HC: N = 132
ADHD: N = 128
Part A 23.70 (7.51) 26.80 (8.24) 11.60 (1,256), p = 0.001* −0.43
Part B 50.06 (17.30) 57.89 (20.30) 12.50 (1,254), p < 0.001* −0.44
Part B - A 26.33 (13.51) 31.00 (18.38) 5.88 (1,254), p = 0.016 −0.30
ANCOVA testing the effect of group for each neuropsychological measure, with age and gender as covariates.
†log-transformed variable to a normal distribution.
*indicates p-values surviving correction for the effective number of independent tests conducted (N = 22, significance threshold (type 1 error rate 
at 5%) = 0.0023)(Li and Ji, 2005).
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